MicroRNA Market Size Worth $6.71 Billion By 2034 | CAGR: 11.50%

The global microRNA market size is expected to reach USD 6.71 billion by 2034, according to a new study by Polaris Market Research. The report “microRNA Market Share, Size, Trends, Industry Analysis Report, By Product (Instrument, Consumables); By Services; By Application; By Region, And Segment Forecasts, 2026-2035” gives a detailed insight into current market dynamics and provides analysis on future market growth.

MicroRNAs are small non-coding RNA molecules that regulate gene expression. They are typically composed of 18 to 24 nucleotides found in plants, animals, and viruses. miRNAs bind to specific messenger RNA (mRNA) molecules, which are the templates for protein synthesis. This binding leads to the degradation of the target mRNA or inhibits its translation, thereby regulating the expression of genes.

miRNAs involve various biological processes, including development, cell differentiation, proliferation, and apoptosis. They act as post-transcriptional regulators and have been found to influence numerous physiological and pathological processes, such as cancer, cardiovascular diseases, and neurological disorders.

The growing focus on mammalian microRNAs (miRNAs) in the context of chronic disorders has led to a shift toward therapeutic strategies for disease treatment and diagnosis. Disruptions in miRNA expression have been associated with various conditions, and targeting these dysregulated miRNAs using inhibitors or mimics shows promise as a potential therapeutic approach.

The potential of miRNAs in diagnosing and treating chronic diseases, including cancer, liver disease, neurological disorders, infectious diseases, coronary heart disease, and metabolic diseases, is widely recognized. In the case of cancer, certain overexpressed miRNAs act as oncogenes, while others expressed at low levels in cancer cells function as tumor suppressor miRNAs, such as Let-7. These insights into the role of miRNAs in disease have fueled the demand for miRNA-based therapeutics, driving the growth of the miRNA market.

Continuing research and clinical trials on miRNA have expanded their applications in clinical and preclinical settings. Numerous studies indicate the potential of miRNAs as regulators of drug resistance, biomarkers for various pathological conditions, and therapeutic agents for medical intervention across a wide range of human health conditions. The increasing number of clinical trials assessing the effectiveness of miRNA in treating various chronic diseases is a significant factor driving the growth of the miRNA market during the forecast period.

MicroRNA Market Report Highlights

• North America led the market with a 41.2% revenue share in 2025. The presence of key market players and extensive R&D contribute to the regional market dominance.
• Asia Pacific is projected to witness the fastest growth at a 12.8% CAGR. Advancements in genomic technologies drive the regional market growth.
• The consumables segment led with a 58.6% market share in 2025. This is owing to the wide range of consumables available for microRNA profiling.
• The cancer segment accounted for the largest market share of 36.9% in 2025. The rising prevalence of cancer cases contributes to the segment’s leading position.
• The isolation & purification segment is projected to witness the fastest growth at a 13.4% CAGR. This is due to the increasing introduction of specialized kits designed for accurate results
• Some of the major players operating in the global market include Biosensors International Group, Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co.KG, C. R. Bard, Inc., Boston Scientific Corporation, Cook Medicals, Lepu Medicals, and Liaoning Biomedical Materials.

Request a free sample copy or read the full market insights: MicroRNA Market

Polaris Market Research has segmented microRNA market report based on products, services, application, and region:

MicroRNA, Products Outlook (Revenue - USD Billion, 2021-2034)

• Instrument
• Consumables

MicroRNA, Services Outlook (Revenue - USD Billion, 2021-2034)

• Service Type
• Isolation & Purification
• miRNA cDNA Synthesis
• Profiling, Localization, & Quantification
• Functional Analysis
• Others
• Specimen
• Whole Blood
• Serum
• Plasma
• FFPE
• Fresh Frozen Tissue
• Others

MicroRNA, Application Outlook (Revenue - USD Billion, 2021-2034)

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

MicroRNA, Regional Outlook (Revenue - USD Billion, 2021-2034)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa

MicroRNA Market Report Scope

Report Attributes	Details
Market size value in 2025	USD 2.52 billion
Revenue forecast in 2034	USD 6.71 billion
CAGR	11.50% from 2026 - 2034
Base year	2025
Historical data	2021 - 2024
Forecast period	2026 - 2034
Quantitative units	Revenue in USD billion and CAGR from 2026 to 2034
Segments covered	By products, services, application, By Region
Regional scope	North America, Europe, Asia Pacific, Latin America; Middle East & Africa
Customization	Report customization as per your requirements with respect to countries, region and segmentation.
For Specific Research Requirements	Request Customization

Source: Polaris Market Research Analysis